<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>OrthoSpineNews &#187; Neuro</title>
	<atom:link href="http://www.orthospinenews.com/category/neuro/feed" rel="self" type="application/rss+xml" />
	<link>http://www.orthospinenews.com</link>
	<description>The latest news for the orthopedic and spine industries</description>
	<lastBuildDate>Fri, 03 Feb 2012 17:40:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>OrthoNeuro Technologies Announces an Exclusive Partnership with Southern California University of Health Sciences</title>
		<link>http://www.orthospinenews.com/orthoneuro-technologies-announces-an-exclusive-partnership-with-southern-california-university-of-health-sciences</link>
		<comments>http://www.orthospinenews.com/orthoneuro-technologies-announces-an-exclusive-partnership-with-southern-california-university-of-health-sciences#comments</comments>
		<pubDate>Tue, 31 Jan 2012 15:41:48 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[Agreement]]></category>
		<category><![CDATA[orthoneuro]]></category>
		<category><![CDATA[partnership]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=6189</guid>
		<description><![CDATA[OrthoNeuro Technologies, Inc. (http://www.ortho-neuro.com), a technology company that designs and integrates products and services focused on technique skills development to increase proficiency in the Spinal Care Professional community, announces an exclusive partnership to provide the Dynadjust Spinal Manipulation Training System ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/orthoneuro-technologies-announces-an-exclusive-partnership-with-southern-california-university-of-health-sciences/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>InVivo Therapeutics Co-Founder Dr. Robert S. Langer Awarded Annual Innovation Award from The Economist</title>
		<link>http://www.orthospinenews.com/invivo-therapeutics-co-founder-dr-robert-s-langer-awarded-annual-innovation-award-from-the-economist</link>
		<comments>http://www.orthospinenews.com/invivo-therapeutics-co-founder-dr-robert-s-langer-awarded-annual-innovation-award-from-the-economist#comments</comments>
		<pubDate>Mon, 12 Dec 2011 17:32:12 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[award]]></category>
		<category><![CDATA[InViVo]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=5892</guid>
		<description><![CDATA[CAMBRIDGE, Mass., Dec 12, 2011 (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. (otc/bb:NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today congratulates Robert S. Langer, Sc.D., InVivo co-founder and member ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/invivo-therapeutics-co-founder-dr-robert-s-langer-awarded-annual-innovation-award-from-the-economist/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain</title>
		<link>http://www.orthospinenews.com/spinal-modulation-system-receives-ce-mark-for-the-management-of-chronic-intractable-pain</link>
		<comments>http://www.orthospinenews.com/spinal-modulation-system-receives-ce-mark-for-the-management-of-chronic-intractable-pain#comments</comments>
		<pubDate>Fri, 09 Dec 2011 15:54:59 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[CE Mark]]></category>
		<category><![CDATA[Spinal modulation]]></category>
		<category><![CDATA[stimulator]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=5874</guid>
		<description><![CDATA[LAS VEGAS, Dec 08, 2011 (BUSINESS WIRE) -- Spinal Modulation, a privately held global medical device company, announced today that the Spinal Modulation Neurostimulator System has received the CE Mark for the management of chronic intractable pain. The Spinal Modulation ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/spinal-modulation-system-receives-ce-mark-for-the-management-of-chronic-intractable-pain/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Paralyzed man stands, steps after spine treatment</title>
		<link>http://www.orthospinenews.com/paralyzed-man-stands-steps-after-spine-treatment</link>
		<comments>http://www.orthospinenews.com/paralyzed-man-stands-steps-after-spine-treatment#comments</comments>
		<pubDate>Fri, 20 May 2011 17:17:49 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[paralyzed]]></category>
		<category><![CDATA[spinal cord]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=5441</guid>
		<description><![CDATA[NEW YORK (Reuters) – A man left paralyzed after a car accident was able to stand and take steps after electrical stimulation of his spinal cord in what researchers described as a breakthrough in treating such devastating injuries. Rob Summers, ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/paralyzed-man-stands-steps-after-spine-treatment/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology</title>
		<link>http://www.orthospinenews.com/neostem-announces-agreement-with-shijiazhuang-third-hospital-in-the-provincial-capital-of-hebei-province-china-to-offer-orthopedic-applications-based-on-neostem%e2%80%99s-licensed-technology</link>
		<comments>http://www.orthospinenews.com/neostem-announces-agreement-with-shijiazhuang-third-hospital-in-the-provincial-capital-of-hebei-province-china-to-offer-orthopedic-applications-based-on-neostem%e2%80%99s-licensed-technology#comments</comments>
		<pubDate>Thu, 09 Dec 2010 15:57:27 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[Agreement]]></category>
		<category><![CDATA[milestone]]></category>
		<category><![CDATA[Neostem]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=4707</guid>
		<description><![CDATA[NEW YORK, Dec. 9, 2010 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units – U.S. adult stem cells, China adult stem ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/neostem-announces-agreement-with-shijiazhuang-third-hospital-in-the-provincial-capital-of-hebei-province-china-to-offer-orthopedic-applications-based-on-neostem%e2%80%99s-licensed-technology/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>InVivo exceeds private placement by $2.5M</title>
		<link>http://www.orthospinenews.com/invivo-exceeds-private-placement-by-2-5m</link>
		<comments>http://www.orthospinenews.com/invivo-exceeds-private-placement-by-2-5m#comments</comments>
		<pubDate>Mon, 06 Dec 2010 15:42:56 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[InViVo]]></category>
		<category><![CDATA[raised]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=4610</guid>
		<description><![CDATA[InVivo Therapeutics today said that its previously announced $10.5 million private placement actually brought in $13 milion with additional units being purchased by Spencer Trask Ventures Inc., which served as placement agent and financial advisor. InVivo, a Cambridge company working ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/invivo-exceeds-private-placement-by-2-5m/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vycor Medical Announces Acquisition of Therapeutic and Diagnostic Vision Restoration Company &#8212; NovaVision</title>
		<link>http://www.orthospinenews.com/vycor-medical-announces-acquisition-of-therapeutic-and-diagnostic-vision-restoration-company-novavision</link>
		<comments>http://www.orthospinenews.com/vycor-medical-announces-acquisition-of-therapeutic-and-diagnostic-vision-restoration-company-novavision#comments</comments>
		<pubDate>Fri, 12 Nov 2010 16:04:03 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[vision]]></category>
		<category><![CDATA[vycor]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=4540</guid>
		<description><![CDATA[BOHEMIA, NY, Nov 12, 2010 (MARKETWIRE via COMTEX) -- Vycor Medical, Inc. (OTCBB: VYCO &#124; PowerRating) (www.vycormedical.com), a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced the entry into a purchase agreement to acquire the assets of ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/vycor-medical-announces-acquisition-of-therapeutic-and-diagnostic-vision-restoration-company-novavision/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>InVivo Therapeutics opens Medford facility</title>
		<link>http://www.orthospinenews.com/invivo-therapeutics-opens-medford-facility</link>
		<comments>http://www.orthospinenews.com/invivo-therapeutics-opens-medford-facility#comments</comments>
		<pubDate>Tue, 02 Nov 2010 16:59:51 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[Expansion]]></category>
		<category><![CDATA[facility]]></category>
		<category><![CDATA[InViVo]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=4504</guid>
		<description><![CDATA[InVivo Therapeutics Corp., a life sciences company developing technologies for the treatment of spinal cord injuries, has signed a lease to open its first manufacturing and development facility in Medford. The company will use the facility to ramp up production ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/invivo-therapeutics-opens-medford-facility/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Neuralstem Awarded Three Federal Grants</title>
		<link>http://www.orthospinenews.com/neuralstem-awarded-three-federal-grants</link>
		<comments>http://www.orthospinenews.com/neuralstem-awarded-three-federal-grants#comments</comments>
		<pubDate>Tue, 02 Nov 2010 16:58:55 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[federal grants]]></category>
		<category><![CDATA[neuralstem]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=4502</guid>
		<description><![CDATA[ROCKVILLE, Md., Nov. 2, 2010 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has been awarded three Federal grants, totaling $733,438 through the Patient Protection and Affordable Care Act, which supports investments in qualifying therapeutic discovery projects. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO ) "This money ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/neuralstem-awarded-three-federal-grants/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zynex Announces New Chief Financial Officer</title>
		<link>http://www.orthospinenews.com/zynex-announces-new-chief-financial-officer</link>
		<comments>http://www.orthospinenews.com/zynex-announces-new-chief-financial-officer#comments</comments>
		<pubDate>Fri, 27 Aug 2010 17:20:52 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[Appointment]]></category>
		<category><![CDATA[cfo]]></category>
		<category><![CDATA[hire]]></category>
		<category><![CDATA[zynex]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=4315</guid>
		<description><![CDATA[LITTLETON, Colo.--(BUSINESS WIRE)--Zynex, Inc. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that Anthony Scalese has been named Chief Financial Officer. Mr. Scalese will start on September 7, 2010, and will ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/zynex-announces-new-chief-financial-officer/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stryker Said to Be in Talks on Boston Scientific Unit</title>
		<link>http://www.orthospinenews.com/stryker-said-to-be-in-talks-on-boston-scientific-unit</link>
		<comments>http://www.orthospinenews.com/stryker-said-to-be-in-talks-on-boston-scientific-unit#comments</comments>
		<pubDate>Wed, 18 Aug 2010 15:53:36 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[acquisition]]></category>
		<category><![CDATA[boston scientific]]></category>
		<category><![CDATA[Stryker]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=4269</guid>
		<description><![CDATA[Aug. 17 (Bloomberg) -- Stryker Corp., a maker of artificial hips and knees, is in advanced talks to buy Boston Scientific Corp.’s pain-management device unit for about $1.5 billion, said three people with knowledge of the transaction. An agreement for ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/stryker-said-to-be-in-talks-on-boston-scientific-unit/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>J&amp;J Buying Stroke-Treatment Co Micrus For $480M</title>
		<link>http://www.orthospinenews.com/jj-buying-stroke-treatment-co-micrus-for-480m</link>
		<comments>http://www.orthospinenews.com/jj-buying-stroke-treatment-co-micrus-for-480m#comments</comments>
		<pubDate>Wed, 14 Jul 2010 18:01:55 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[micrus]]></category>
		<category><![CDATA[stroke]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=4085</guid>
		<description><![CDATA[Johnson &#38; Johnson (JNJ) said Monday it plans to bolster its lineup of stroke-prevention products by buying Micrus Endovascular Corp. (MEND) for about $480 million, marking the latest deal in a neurovascular-device market that appears to be heating up. J&#38;J's ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/jj-buying-stroke-treatment-co-micrus-for-480m/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medtronic Launches Award-Winning Neuro Oncology Surgical Imaging System in the United States</title>
		<link>http://www.orthospinenews.com/medtronic-launches-award-winning-neuro-oncology-surgical-imaging-system-in-the-united-states</link>
		<comments>http://www.orthospinenews.com/medtronic-launches-award-winning-neuro-oncology-surgical-imaging-system-in-the-united-states#comments</comments>
		<pubDate>Mon, 26 Apr 2010 16:12:04 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[Imaging]]></category>
		<category><![CDATA[medtronic]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=3705</guid>
		<description><![CDATA[MINNEAPOLIS--(BUSINESS WIRE)--Medtronic (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions. Providing real-time imaging in the operating room (OR), the ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/medtronic-launches-award-winning-neuro-oncology-surgical-imaging-system-in-the-united-states/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Axerion gets $750,000 for neuro research</title>
		<link>http://www.orthospinenews.com/axerion-gets-750000-for-neuro-research</link>
		<comments>http://www.orthospinenews.com/axerion-gets-750000-for-neuro-research#comments</comments>
		<pubDate>Mon, 05 Apr 2010 17:19:17 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[axerion]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[raised]]></category>
		<category><![CDATA[research]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=3569</guid>
		<description><![CDATA[Connecticut Innovations today said it has invested $750,000 in New Haven-based Axerion Therapeutics Inc., a Yale University spinoff that is developing treatments for neurological injuries and diseases. Axerion was founded by Scheer &#38; Co., and Yale faculty member Stephen Strittmatter. ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/axerion-gets-750000-for-neuro-research/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Acorda Therapeutics Announces Filing of Patent Extension Applications for AMPYRA(TM) (dalfampridine)</title>
		<link>http://www.orthospinenews.com/acorda-therapeutics-announces-filing-of-patent-extension-applications-for-ampyratm-dalfampridine</link>
		<comments>http://www.orthospinenews.com/acorda-therapeutics-announces-filing-of-patent-extension-applications-for-ampyratm-dalfampridine#comments</comments>
		<pubDate>Mon, 22 Mar 2010 16:21:01 +0000</pubDate>
		<dc:creator>Josh Sandberg</dc:creator>
				<category><![CDATA[Neuro]]></category>
		<category><![CDATA[acorda]]></category>
		<category><![CDATA[ampyra]]></category>
		<category><![CDATA[patent]]></category>

		<guid isPermaLink="false">http://www.orthospinenews.com/?p=3478</guid>
		<description><![CDATA[HAWTHORNE, N.Y., Mar 22, 2010 (BUSINESS WIRE) -- Acorda Therapeutics, Inc. (ACOR 34.95, +0.11, +0.32%)today announced that the Company has submitted applications to extend patent protection for AMPYRA(TM) (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office (USPTO). ...]]></description>
		<wfw:commentRss>http://www.orthospinenews.com/acorda-therapeutics-announces-filing-of-patent-extension-applications-for-ampyratm-dalfampridine/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

